查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1844181

空輸液袋市場按材料類型、容量、最終用戶、分銷管道和應用分類－2025-2032年全球預測

Empty IV Bags Market by Material Type, Volume, End User, Distribution Channel, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，空輸液袋市場規模將達到 62.4 億美元，複合年成長率為 5.69%。

主要市場統計數據
基準年 2024 40億美元
預計年份：2025年 42.3億美元
預測年份：2032年 62.4億美元
複合年成長率 (%) 5.69%

本文全面概述了材料創新、監管變化和不斷發展的醫療服務模式如何重新定義空輸液袋的臨床和供應鏈優先事項。

空輸液袋環節涉及臨床、供應鏈工程和材料科學等多個領域，因此對於以安全性、便攜性和成本效益為優先的醫療服務模式至關重要。近年來，製造、採購和臨床營運等各相關人員積極應對不斷變化的監管要求，推動了可萃取物和可萃取物的研發，促使他們轉向其他聚合物化學材料，並拓展了除傳統醫院藥房之外的分銷管道。隨著以患者為中心的護理和居家醫療的快速發展，輸液容器的設計和可用性直接影響治療流程、庫存計劃和無菌物流。

醫療服務提供者和供應商也在適應新的採購模式。醫院和診所要求更高的無菌性、可預測的保存期限以及與多種療法的兼容性，而家庭護理服務提供者則優先考慮便攜性、易用性和安全處置。這些日益成長的壓力促使製造商在薄膜擠出、焊接技術和無菌填充工藝方面進行創新，並與材料專家和契約製造製造商合作，以提供差異化的產品特性。因此，空輸液袋的市場格局不再僅僅由設備外形決定，而是由一個連接原料採購、製造精度、分銷可靠性和臨床性能的生態系統決定。

為什麼材料替代、分散式護理、多元化分銷和加強監管正在從根本上改變製造和採購的動態

隨著醫療服務體系的技術成熟和結構性變革，空輸液袋市場正經歷幾個變革性的轉變。首先，從傳統的PVC配方轉向非PVC配方，既反映了監管機構的嚴格審查，也反映了臨床醫生對減少塑化劑遷移的需求。這項轉變推動了EVA和聚乙烯配方的新一輪研發，力求在柔韌性、阻隔性能和加工性能之間取得平衡。同時，隨著供應商尋求降低地緣政治事件和物流中斷對其供應鏈的風險，生產規模和地理分佈也在重新評估。

其次，分散式醫療模式（例如家庭輸液和不斷擴展的門診服務）的興起，催生了對更多規格和包裝形式的藥品的需求，以支持便攜性和便捷給藥。第三，分銷通路正在多元化。雖然醫院藥局仍然是主要的採購點，但線上藥局平台和現代零售藥局正成為某些產品領域的重要接觸點，這改變了庫存管理預期和監管方式。最後，強調適用性、可萃取物檢測和上市後競爭監測的法規，將品質保證置於競爭優勢的最前沿，促使製造商採用完善的驗證通訊協定和可追溯性系統，以增強臨床醫生的信心並獲得支付方的認可。

2025年關稅調整對空輸液袋供應鏈的採購、近岸外包和製造彈性的綜合影響

2025年關稅和貿易措施帶來的政策環境正在對空輸液袋價值鏈的籌資策略、成本結構和供應商選擇產生累積影響。對聚合物進口及相關醫用級包裝組件徵收的關稅增加了部分成品和原料的總到岸成本，促使採購團隊重新評估其供應商組合，並加快對更靠近終端市場的替代供應商進行資格認證。為此，許多製造商正在調整其供應商結構，傾向於選擇國內或近岸合作夥伴，而另一些製造商則正在尋求材料改良策略，以減少對高關稅原料的依賴。

這些變化也影響資本配置決策。面對投入成本波動加劇，製造商優先投資於彈性擠出生產線和模組化無塵室設施，以便快速切換PVC和非PVC材料，避免關稅造成的生產中斷。分銷合作夥伴和醫院系統則透過增加關鍵SKU的庫存緩衝措施來應對，同時收緊供應商的績效考核指標。此外，關稅環境凸顯了全面成本效益分析的重要性，該分析應涵蓋關稅、運費和合規成本，迫使買賣雙方尋求風險共擔、激勵獎勵而非僅僅追求銷售的合約安排。

策略性細分考量將材料化學、銷售因素、終端用戶需求、分銷管道和臨床應用限制等因素與競爭定位聯繫起來。

有效的細分主導策略能夠識別材料成分、容器容量、終端用戶需求、分銷管道和臨床應用等方面的差異，並據此調整產品開發和開發方法。目前，材料分為聚氯乙烯（PVC）基材料和非PVC基材料，製造商將研發重點放在非PVC材料中的乙烯醋酸乙烯共聚物（EVA）和聚乙烯上，以期在柔韌性、化學相容性和生產效率之間取得理想的平衡。材料的選擇必須與臨床應用的需求相符，因為它直接影響滅菌方式、儲存穩定性以及與親油性或敏感藥物製劑的相容性。

容量範圍從​​緊湊型 100 毫升到大型 1000 毫升，還包括 250 毫升和 500 毫升的中型容量，這導致在操作人體工學、添加劑需求和運輸經濟性等方面需要權衡設計。診所和居家醫療機構優先考慮易用性、簡化的給藥方式和安全處置，而醫院則要求容量、與輸液系統的互通性以及嚴格的品質文件。即使在醫院內部，公立醫院和私立醫院也可能有不同的採購法規和品質驗收標準，因此需要不同的合約方式。分銷管道影響藥品的供應和客戶體驗：醫院藥房專注於批量採購和連鎖物流；線上藥房創建直接面對消費者的管道，需要清晰的標籤檢視和退貨處理；而零售藥房則注重提高照護現場的取藥便利性，重點關注貨架陳列和員工培訓。用於脫水治療的產品需要強大的屏障性能和清晰的劑量說明；藥物遞送系統需要與多種活性藥物成分相容；而營養支持，無論是中心給藥還是外周給藥，都需要能夠保持營養成分穩定性並支持無菌製劑通訊協定的解決方案。透過沿著每個細分維度調整產品系列，製造商和負責人可以最佳化臨床適用性、法規合規性和商業性成功。

分析美洲、歐洲、中東和非洲以及亞太地區的區域動態和採購偏好，為採購、監管策略和分銷模式提供資訊。

每個地區的動態差異顯著，為相關人員在製定與各地區醫療服務模式和管理體制相適應的供應策略時帶來了不同的機會和風險。在美洲，採購往往優先考慮供應商的可追溯性、嚴格遵守藥典標準以及適應大型綜合醫療體系。在歐洲、中東和非洲，監管環境各不相同，各國衛生部門和競標流程都會影響產品的推廣週期；與區域經銷商和契約製造製造商建立策略夥伴關係可以加速市場滲透。在中東和非洲，基礎設施的限制以及不斷成長的私營部門投資正在推動對可靠、易用的產品的需求，以支持居家醫療和門診護理。

亞太地區都市區三級醫療中心正迅速推進醫療器材的臨床應用，並專注於發展在地化生產以支援國家醫療設備策略。區域供應鏈也正在適應出口主導動態和強調價值導向型採購的採購改革。在整個亞太地區，物流因素、關稅風險和當地監管要求都在影響採購決策，成功的供應商正將本地監管專業知識與靈活的生產佈局相結合，以滿足客戶多樣化的需求。

卓越的製造流程、材料創新、監管領導力和靈活的分銷能力如何定義市場領導地位和供應商差異化

在空輸液袋領域，競爭地位越來越取決於製造流程、材料科學能力、監管領導力和分銷靈活性的綜合考量。領先的供應商正加大研發投入，以最佳化聚合物的萃取和浸出性能，同時拓展滅菌和無菌填充能力，從而滿足醫療機構的採購標準。同時，受託製造製造商也正在擴大無塵室，並實施先進的製程控制，以減少批次差異，加快供應商與醫院系統和集團採購組織的認證進程。

材料專家、醫療器材製造商和醫療保健機構之間的策略合作正在打造差異化的產品線，這些產品線強調臨床醫生使用便利性、藥物相容性以及永續性考量，例如減少廢棄物和提高可回收性。提供整合低溫運輸物流、庫存管理解決方案和數位化訂購介面的分銷合作夥伴在分散的醫療保健環境中獲得了更廣泛的應用。最終，那些將技術性能與透明的品質系統、響應迅速的客戶服務和靈活的生產佈局相結合的公司，最有利於建立長期的機構合作關係，並能靈活應對政策變化和採購改革。

為製造商和供應商提供切實可行的營運和策略舉措，以增強韌性、加速臨床應用並適應不斷變化的採購優先事項。

產業領導者戰術性行動，以增強韌性，加速臨床差異化產品的推廣應用，並使商業模式與不斷變化的支付方和醫療服務提供者的期望保持一致。首先，應優先考慮材料多樣化和製程靈活性，對PVC和非PVC平台進行認證，並對生產線維修以實現快速切換。其次，應透過投資於可萃取物和可浸出物測試、完善的穩定性方案以及透明的可追溯性，加強監管和品質保證能力，減少採購障礙，並加快醫院認證進程。

第三，我們正在重組分銷策略，以支持分散式醫療保健。我們正在開發適用於家庭輸液和門診環境的包裝和給藥方式，並與數位藥房平台合作，在允許的情況下實現直接送藥上門。第四，我們正在尋求近岸製造夥伴關係和策略性庫存佈局，以降低運費和關稅負擔，同時保持成本競爭力。最後，我們正在透過展示總體擁有成本 (TCO) 優勢、提高病患安全性和工作流程效率，使我們的商業模式與以金額為準的採購保持一致。

嚴謹的混合方法研究途徑，結合了主要相關人員訪談、技術文獻綜述、監管調查和情境三角驗證，確保了分析的有效性。

本報告的調查方法結合了對主要相關人員的訪談、可靠的二手資訊綜合以及系統性的三角驗證，以確保分析的嚴謹性和實際應用價值。主要研究包括對製造業企業高管、醫院和診所採購負責人、參與輸液治療的臨床負責人、委託製造。二手研究包括對監管指南、聚合物性能和萃取物測試的技術文獻、貿易政策文件以及披露資本投資和產能擴張的公開文件的全面審查。

我們採用三角測量法對數據進行綜合分析，該方法將定性研究結果與供應商公告和監管揭露進行交叉檢驗，並透過情境分析評估關稅的營運影響。在適當情況下，我們還使用用例來說明成功的產品導入和近岸外包舉措，並與行業專家查核點檢驗，以驗證有關生產前置作業時間、滅菌方法和分銷模式的假設。這種綜合方法確保結論既反映了實際營運情況，也反映了更廣泛的政策技術背景。

對材料、製造、監管和分銷變化的前瞻性綜合分析，揭示了空輸液袋相關人員的應對能力以及其臨床應用路徑。

總之，空輸液袋產業正經歷著由材料創新、醫療服務模式演變、分銷管道多元化以及政策主導的供應鏈調整所驅動的重大變革時期。積極適應的相關人員——例如透過材料多元化、投資彈性製造、加強監管和品質體係以及調整分銷策略以適應分散式醫療服務——將更有利於獲得臨床應用並有效控制成本波動。貿易政策變化帶來的累積影響凸顯了供應鏈韌性以及透過風險分擔和獎勵可靠性的合作性商業安排的重要性。

展望未來，製造商、醫療服務提供者和經銷商必須在整個價值鏈上通力合作，確保產品設計、監管證據和物流能力得到整合，從而滿足臨床安全和營運效率的雙重需求。這樣做將有助於建立更可靠的輸液治療管道，支持居家醫療和門診護理的擴展，並建立透明且行之有效的長期供應商-買家關係。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 用於空輸液袋製造的可生物分解聚合物配方，以滿足永續性目標
  • 整合RFID追蹤與區塊鏈系統，實現空輸液袋供應鏈的即時透明化
  • 在全球產能受限的情況下，將空輸液袋生產外包給專業合約生產商的做法正在興起。
  • 為滿足複雜的藥物配製通訊協定，模組化多腔空輸液袋的需求日益成長。
  • 嚴格遵守不含鄰苯二甲酸酯且低析出物的空輸液袋材料的監管規定
  • 醫院藥局開始採用現場3D列印技術，為特殊治療方法訂製空輸液袋
  • 塑膠樹脂供應商與輸液袋製造商建立策略夥伴關係關係，確保原料供應。

第6章美國關稅的累積影響，2025年

第7章 人工智慧的累積影響，2025年

8. 依材料類型分類的空輸液袋市場

  • 不含聚氯乙烯
    • EVA
    • 聚乙烯
  • PVC

9. 空輸液袋市場（以銷售量計）

  • 100mL
  • 1,000mL
  • 250mL
  • 500mL

第10章 按終端用戶分類的空輸液袋市場

  • 診所
  • 居家醫療
  • 醫院
    • 公立醫院
    • 私立醫院

第11章 按通路分類的空輸液袋市場

  • 醫院藥房
  • 網路藥房
  • 零售藥房

第12章 按應用分類的空輸液袋市場

  • 脫水療法
  • 藥物遞送
  • 營養支持
    • 中樞營養
    • 周邊營養

第13章 空輸液袋市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 依組別分類的空輸液袋市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國空輸液袋市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Baxter International, Inc.
    • B. Braun Melsungen AG
    • Fresenius Kabi AG
    • Terumo Corporation
    • ICU Medical, Inc.
    • Nipro Corporation
    • Grifols, SA
    • Vygon SA
    • Poly Medicure Limited
    • Pfizer Inc.
Product Code: MRR-ED54C46E8A16

The Empty IV Bags Market is projected to grow by USD 6.24 billion at a CAGR of 5.69% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 4.00 billion
Estimated Year [2025] USD 4.23 billion
Forecast Year [2032] USD 6.24 billion
CAGR (%) 5.69%

An integrative overview of how materials innovation, regulatory shifts, and evolving care delivery models are redefining clinical and supply chain priorities for empty IV bags

The empty intravenous (IV) bag sector sits at the intersection of clinical practice, supply chain engineering, and material science, and it has become increasingly central to healthcare delivery models that prioritize safety, portability, and cost-efficiency. Over recent years, stakeholders across manufacturing, procurement, and clinical operations have navigated evolving regulatory expectations for leachables and extractables, driven a transition toward alternative polymer chemistries, and responded to distribution channel diversification that extends beyond traditional hospital pharmacies. As patient-centric care and homecare expansion accelerate, the design and availability of IV containers now directly influence therapeutic workflows, inventory planning, and sterile logistics.

Healthcare providers and suppliers are also adjusting to new procurement paradigms. Hospitals and clinics seek higher assurance of sterility, predictable shelf life, and compatibility with a broader range of therapeutic agents, while homecare providers emphasize portability, ease of use, and safe disposal. These converging pressures are prompting manufacturers to innovate in film extrusion, welding technologies, and sterile filling processes, and they are stimulating partnerships with materials specialists and contract manufacturers to deliver differentiated product attributes. Consequently, the market context for empty IV bags is defined not just by device form factors, but by an ecosystem that connects raw material sourcing, manufacturing fidelity, distribution reliability, and clinical performance.

How material substitution, decentralized care, distribution diversification, and elevated regulatory focus are fundamentally transforming manufacturing and procurement dynamics

Several transformative shifts are reshaping the empty IV bag landscape, bridging technological maturation with structural changes in healthcare delivery. First, material substitution away from legacy PVC formulations toward non-PVC alternatives reflects both regulatory scrutiny and clinician demand for reduced plasticizer migration; this pivot is prompting new development cycles in EVA and polyethylene formulations that balance flexibility, barrier properties, and processability. At the same time, manufacturing scale and geographic diversification are being reconsidered as suppliers seek to de-risk supply chains exposed by geopolitical events and logistics disruptions.

Second, the rise of decentralized care models, including expanded home infusion and ambulatory services, is creating demand for a broader array of bag volumes and packaging configurations that support portability and simplified administration. Third, distribution channels are diversifying: while hospital pharmacies remain core procurement points, online pharmacy platforms and modern retail pharmacies are becoming meaningful conduits for certain product segments, which changes inventory management expectations and regulatory oversight. Finally, regulatory emphasis on compatibility, extractables testing, and post-market surveillance is elevating quality assurance as a competitive differentiator, encouraging manufacturers to adopt robust validation protocols and traceability systems that support clinician confidence and payer acceptance.

The compound consequences of 2025 tariff adjustments on procurement, nearshoring, and manufacturing flexibility across the empty IV bag supply chain

The policy environment created by tariffs and trade actions in 2025 has had a cumulative effect on sourcing strategies, cost structures, and supplier selection across the empty IV bag value chain. Tariffs on polymer imports and related medical-grade packaging components have increased the total landed cost of some finished goods and raw inputs, prompting procurement teams to reassess supplier portfolios and to accelerate qualification of alternative vendors closer to end markets. In response, many manufacturers have reweighted their supplier mixes to favor domestic or nearshore partners, while others have pursued material reformulation strategies that reduce reliance on tariffed feedstocks.

These shifts also affect capital allocation decisions. Faced with higher input volatility, manufacturers are prioritizing investments in flexible extrusion lines and modular cleanroom facilities that enable quicker changeovers between PVC and non-PVC materials, thereby insulating production from tariff-driven disruptions. Distribution partners and hospital systems have responded by increasing inventory buffer policies for critical SKUs while implementing tighter vendor performance metrics. Moreover, the tariff environment has accentuated the importance of comprehensive cost-to-serve analyses that incorporate duties, freight, and regulatory compliance costs, compelling both buyers and suppliers to pursue contractual arrangements that share risk and incentivize resilience rather than volume alone.

Strategic segmentation insights linking material chemistries, volume form factors, end-user requirements, distribution channels, and clinical application constraints to competitive positioning

An effective segmentation-driven strategy recognizes differences in material composition, container volume, end-user requirements, distribution pathways, and clinical applications, and tailors product development and Go-to-Market approaches accordingly. Materials now bifurcate into PVC and non-PVC families, and within the non-PVC category manufacturers are focusing development efforts on ethylene-vinyl acetate (EVA) and polyethylene to achieve the desired balance of flexibility, chemical compatibility, and manufacturing throughput. This material choice directly influences sterilization options, shelf stability, and compatibility with lipophilic or sensitive drug formulations, and therefore must be matched to clinical application needs.

Volume segmentation-ranging from compact 100 mL formats to large 1000 mL reservoirs, including intermediate 250 mL and 500 mL sizes-drives design trade-offs in handling ergonomics, additive requirements, and transport economies. End users present distinct priorities: clinics and homecare environments emphasize ease of use, simplified administration, and safe disposal, while hospitals demand scale, interoperability with infusion systems, and rigorous quality documentation; within hospitals, government institutions and private hospitals may follow different procurement rules and quality acceptance criteria, necessitating distinct contractual approaches. Distribution channels shape availability and customer experience, with hospital pharmacies focused on bulk procurement and chain logistics, online pharmacies creating direct-to-consumer pathways that require clear labeling and returns handling, and retail pharmacies offering point-of-care access that emphasizes shelf presentation and staff training. Clinical applications impose their own constraints: products intended for dehydration therapy demand robust barrier performance and dosing clarity, drug delivery requires compatibility with a wide spectrum of active pharmaceutical ingredients, and nutritional support-whether delivered centrally or peripherally-requires solutions that preserve nutrient stability and support aseptic compounding protocols. By aligning product portfolios with each segmentation axis, manufacturers and purchasers can optimize clinical fit, regulatory compliance, and commercial success.

Regional dynamics and procurement preferences across the Americas, Europe Middle East & Africa, and Asia-Pacific that inform sourcing, regulatory strategy, and distribution models

Regional dynamics vary markedly and offer differentiated opportunities and risks for stakeholders that align supply strategies with local healthcare delivery models and regulatory regimes. In the Americas, procurement tends to prioritize robust supplier traceability, compliance with stringent pharmacopoeial standards, and responsiveness to large integrated health systems; thus, manufacturers that demonstrate validated quality systems and domestic or nearshore production capabilities often find stronger adoption. Europe, the Middle East & Africa present a heterogeneous regulatory landscape where national health authorities and tender processes influence adoption cycles, and where strategic partnerships with regional distributors and contract manufacturers can accelerate market penetration. In the Middle East and Africa, infrastructure constraints and growing private sector investment drive demand for reliable, easy-to-use formats that support emergent homecare and ambulatory services.

Asia-Pacific exhibits rapid clinical adoption across urban tertiary centers and a growing emphasis on local manufacturing to meet national medical device strategies; regional supply networks are also adapting to export-led dynamics and to procurement reforms that emphasize value-based purchasing. Across all regions, logistics considerations, tariff exposures, and local regulatory requirements shape sourcing decisions, and successful suppliers combine regional regulatory expertise with flexible production footprints to meet differentiated customer expectations.

How manufacturing excellence, materials innovation, regulatory leadership, and distribution agility are coalescing to define market leadership and supplier differentiation

Competitive positioning in the empty IV bag sector is increasingly determined by a blend of manufacturing excellence, material science capability, regulatory leadership, and distribution agility. Leading suppliers are investing in R&D to optimize polymer formulations for extractable and leachables performance while scaling sterilization and aseptic filling competencies that meet institutional procurement thresholds. In parallel, contract manufacturing organizations are expanding cleanroom capacity and implementing advanced process controls that reduce batch variability and accelerate supplier qualification for hospital systems and group purchasing organizations.

Strategic collaborations between materials specialists, device makers, and healthcare providers are producing differentiated product lines that emphasize clinician usability, pharmacologic compatibility, and sustainability considerations such as reduced waste or improved recyclability. Distribution partners that offer integrated cold chain logistics, inventory management solutions, and digital ordering interfaces are achieving stronger adoption in decentralized care settings. Ultimately, companies that align technical performance with transparent quality systems, responsive customer service, and flexible manufacturing footprints are best positioned to capture long-term institutional relationships and to respond nimbly to policy shifts and procurement reforms.

Actionable operational and strategic initiatives for manufacturers and suppliers to build resilience, accelerate clinical adoption, and align with evolving procurement priorities

Industry leaders should pursue a set of tactical and strategic actions to strengthen resilience, accelerate adoption of clinically differentiated products, and align commercial models with evolving payer and provider expectations. First, prioritize material diversification and process flexibility by qualifying both PVC and non-PVC platforms and by retrofitting production lines for rapid changeovers; this reduces exposure to tariff shocks and raw material supply disruptions. Second, deepen regulatory and quality assurance capabilities by investing in extractables and leachables testing, robust stability protocols, and transparent traceability that reduce procurement barriers and accelerate hospital qualification timelines.

Third, reconfigure distribution strategies to support decentralized care: develop packaging and dosing formats for home infusion and ambulatory settings, and partner with digital pharmacy platforms to enable direct-to-patient fulfillment where permitted. Fourth, pursue nearshore manufacturing partnerships or strategic inventory positioning to mitigate freight and tariff exposures while maintaining cost-competitiveness. Finally, align commercial models with value-based procurement by demonstrating total cost of ownership benefits, improved patient safety profiles, or workflow efficiencies; this may involve bundled service offerings, performance-based contracts, or clinician training programs that reduce adoption friction.

A rigorous mixed-methods research approach combining primary stakeholder interviews, technical literature synthesis, regulatory review, and scenario-based triangulation to ensure analytical validity

The research methodology underpinning this report combines primary stakeholder engagement, robust secondary source synthesis, and systematic triangulation to ensure analytical rigor and practical relevance. Primary research included structured interviews with manufacturing executives, procurement leads from hospitals and clinics, clinical leadership involved in infusion therapy, contract manufacturers, and distribution partners; these conversations provided qualitative insights into production constraints, procurement priorities, and clinical usability considerations. Secondary research comprised a comprehensive review of regulatory guidance, technical literature on polymer performance and extractables testing, trade policy documents, and public filings that illuminate capital investments and capacity expansions.

Data were synthesized using a triangulation approach that cross-validated qualitative findings with supplier announcements and regulatory disclosures, and that assessed the operational implications of tariff actions through scenario analysis. Where appropriate, the methodology used case studies to illustrate successful product introductions and nearshoring initiatives, and validation checkpoints were embedded with industry experts to confirm assumptions about manufacturing lead times, sterilization modalities, and distribution models. This combined approach ensured that conclusions reflect both lived operational realities and the broader policy and technological context.

A forward-looking synthesis of material, manufacturing, regulatory, and distribution changes that converge to define resilience and clinical adoption pathways for empty IV bag stakeholders

In conclusion, the empty IV bag sector is experiencing a period of substantive transformation driven by material innovation, evolving care delivery models, distribution channel diversification, and policy-driven supply chain adjustments. Stakeholders that proactively adapt-by diversifying materials, investing in flexible manufacturing, strengthening regulatory and quality systems, and aligning distribution strategies with decentralized care-will be better positioned to capture clinical adoption and to manage cost volatility. The cumulative impacts of trade policy shifts have underscored the need for supply chain resilience and for collaborative commercial arrangements that distribute risk and incentivize reliability.

Moving forward, manufacturers, healthcare providers, and distributors must coordinate across the value chain to ensure that product design, regulatory evidence, and logistical capability converge to meet the twin imperatives of clinical safety and operational efficiency. By doing so, they will enable more reliable infusion therapy pathways, support the expansion of home and ambulatory care, and create enduring supplier-buyer relationships grounded in transparency and performance.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of biodegradable polymer formulations in empty IV bag production to meet sustainability targets
  • 5.2. Integration of RFID tracking and blockchain systems for real-time empty IV bag supply chain transparency
  • 5.3. Increased outsourcing of empty IV bag manufacture to specialized CMOs amid global capacity constraints
  • 5.4. Rising demand for modular multi-chamber empty IV bags catering to complex drug reconstitution protocols
  • 5.5. Stringent regulatory compliance for phthalate-free and low-extractables empty IV bag materials
  • 5.6. Shift towards on-site 3D printing of customized empty IV bags in hospital pharmacies for niche therapies
  • 5.7. Strategic partnerships between plastic resin suppliers and IV bag manufacturers to secure raw material supply

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Empty IV Bags Market, by Material Type

  • 8.1. Non-PVC
    • 8.1.1. EVA
    • 8.1.2. Polyethylene
  • 8.2. PVC

9. Empty IV Bags Market, by Volume

  • 9.1. 100 mL
  • 9.2. 1000 mL
  • 9.3. 250 mL
  • 9.4. 500 mL

10. Empty IV Bags Market, by End User

  • 10.1. Clinics
  • 10.2. Homecare
  • 10.3. Hospitals
    • 10.3.1. Government Hospitals
    • 10.3.2. Private Hospitals

11. Empty IV Bags Market, by Distribution Channel

  • 11.1. Hospital Pharmacies
  • 11.2. Online Pharmacy
  • 11.3. Retail Pharmacies

12. Empty IV Bags Market, by Application

  • 12.1. Dehydration Therapy
  • 12.2. Drug Delivery
  • 12.3. Nutritional Support
    • 12.3.1. Central Nutrition
    • 12.3.2. Peripheral Nutrition

13. Empty IV Bags Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Empty IV Bags Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Empty IV Bags Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Baxter International, Inc.
    • 16.3.2. B. Braun Melsungen AG
    • 16.3.3. Fresenius Kabi AG
    • 16.3.4. Terumo Corporation
    • 16.3.5. ICU Medical, Inc.
    • 16.3.6. Nipro Corporation
    • 16.3.7. Grifols, S.A.
    • 16.3.8. Vygon S.A.
    • 16.3.9. Poly Medicure Limited
    • 16.3.10. Pfizer Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL EMPTY IV BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL EMPTY IV BAGS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL EMPTY IV BAGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL EMPTY IV BAGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS EMPTY IV BAGS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA EMPTY IV BAGS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL EMPTY IV BAGS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. EMPTY IV BAGS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. EMPTY IV BAGS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. EMPTY IV BAGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL EMPTY IV BAGS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL EMPTY IV BAGS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL EMPTY IV BAGS MARKET SIZE, BY NON-PVC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL EMPTY IV BAGS MARKET SIZE, BY NON-PVC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL EMPTY IV BAGS MARKET SIZE, BY NON-PVC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL EMPTY IV BAGS MARKET SIZE, BY NON-PVC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL EMPTY IV BAGS MARKET SIZE, BY NON-PVC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL EMPTY IV BAGS MARKET SIZE, BY NON-PVC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL EMPTY IV BAGS MARKET SIZE, BY EVA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL EMPTY IV BAGS MARKET SIZE, BY EVA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL EMPTY IV BAGS MARKET SIZE, BY EVA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL EMPTY IV BAGS MARKET SIZE, BY EVA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL EMPTY IV BAGS MARKET SIZE, BY EVA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL EMPTY IV BAGS MARKET SIZE, BY EVA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL EMPTY IV BAGS MARKET SIZE, BY POLYETHYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL EMPTY IV BAGS MARKET SIZE, BY POLYETHYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL EMPTY IV BAGS MARKET SIZE, BY POLYETHYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL EMPTY IV BAGS MARKET SIZE, BY POLYETHYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL EMPTY IV BAGS MARKET SIZE, BY POLYETHYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL EMPTY IV BAGS MARKET SIZE, BY POLYETHYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL EMPTY IV BAGS MARKET SIZE, BY PVC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL EMPTY IV BAGS MARKET SIZE, BY PVC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL EMPTY IV BAGS MARKET SIZE, BY PVC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL EMPTY IV BAGS MARKET SIZE, BY PVC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL EMPTY IV BAGS MARKET SIZE, BY PVC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL EMPTY IV BAGS MARKET SIZE, BY PVC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL EMPTY IV BAGS MARKET SIZE, BY 100 ML, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL EMPTY IV BAGS MARKET SIZE, BY 100 ML, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL EMPTY IV BAGS MARKET SIZE, BY 100 ML, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL EMPTY IV BAGS MARKET SIZE, BY 100 ML, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL EMPTY IV BAGS MARKET SIZE, BY 100 ML, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL EMPTY IV BAGS MARKET SIZE, BY 100 ML, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL EMPTY IV BAGS MARKET SIZE, BY 1000 ML, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL EMPTY IV BAGS MARKET SIZE, BY 1000 ML, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL EMPTY IV BAGS MARKET SIZE, BY 1000 ML, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL EMPTY IV BAGS MARKET SIZE, BY 1000 ML, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL EMPTY IV BAGS MARKET SIZE, BY 1000 ML, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL EMPTY IV BAGS MARKET SIZE, BY 1000 ML, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL EMPTY IV BAGS MARKET SIZE, BY 250 ML, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL EMPTY IV BAGS MARKET SIZE, BY 250 ML, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL EMPTY IV BAGS MARKET SIZE, BY 250 ML, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL EMPTY IV BAGS MARKET SIZE, BY 250 ML, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL EMPTY IV BAGS MARKET SIZE, BY 250 ML, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL EMPTY IV BAGS MARKET SIZE, BY 250 ML, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL EMPTY IV BAGS MARKET SIZE, BY 500 ML, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL EMPTY IV BAGS MARKET SIZE, BY 500 ML, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL EMPTY IV BAGS MARKET SIZE, BY 500 ML, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL EMPTY IV BAGS MARKET SIZE, BY 500 ML, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL EMPTY IV BAGS MARKET SIZE, BY 500 ML, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL EMPTY IV BAGS MARKET SIZE, BY 500 ML, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL EMPTY IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL EMPTY IV BAGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL EMPTY IV BAGS MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL EMPTY IV BAGS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL EMPTY IV BAGS MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL EMPTY IV BAGS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL EMPTY IV BAGS MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL EMPTY IV BAGS MARKET SIZE, BY HOMECARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL EMPTY IV BAGS MARKET SIZE, BY HOMECARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL EMPTY IV BAGS MARKET SIZE, BY HOMECARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL EMPTY IV BAGS MARKET SIZE, BY HOMECARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL EMPTY IV BAGS MARKET SIZE, BY HOMECARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL EMPTY IV BAGS MARKET SIZE, BY HOMECARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL EMPTY IV BAGS MARKET SIZE, BY GOVERNMENT HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL EMPTY IV BAGS MARKET SIZE, BY GOVERNMENT HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL EMPTY IV BAGS MARKET SIZE, BY GOVERNMENT HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL EMPTY IV BAGS MARKET SIZE, BY GOVERNMENT HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL EMPTY IV BAGS MARKET SIZE, BY GOVERNMENT HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL EMPTY IV BAGS MARKET SIZE, BY GOVERNMENT HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL EMPTY IV BAGS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL EMPTY IV BAGS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL EMPTY IV BAGS MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL EMPTY IV BAGS MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL EMPTY IV BAGS MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL EMPTY IV BAGS MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL EMPTY IV BAGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL EMPTY IV BAGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL EMPTY IV BAGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL EMPTY IV BAGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL EMPTY IV BAGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL EMPTY IV BAGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL EMPTY IV BAGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL EMPTY IV BAGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL EMPTY IV BAGS MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL EMPTY IV BAGS MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL EMPTY IV BAGS MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL EMPTY IV BAGS MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL EMPTY IV BAGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL EMPTY IV BAGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL EMPTY IV BAGS MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL EMPTY IV BAGS MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL EMPTY IV BAGS MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL EMPTY IV BAGS MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL EMPTY IV BAGS MARKET SIZE, BY DEHYDRATION THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL EMPTY IV BAGS MARKET SIZE, BY DEHYDRATION THERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL EMPTY IV BAGS MARKET SIZE, BY DEHYDRATION THERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL EMPTY IV BAGS MARKET SIZE, BY DEHYDRATION THERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL EMPTY IV BAGS MARKET SIZE, BY DEHYDRATION THERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL EMPTY IV BAGS MARKET SIZE, BY DEHYDRATION THERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL EMPTY IV BAGS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL EMPTY IV BAGS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL EMPTY IV BAGS MARKET SIZE, BY DRUG DELIVERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL EMPTY IV BAGS MARKET SIZE, BY DRUG DELIVERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL EMPTY IV BAGS MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL EMPTY IV BAGS MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL EMPTY IV BAGS MARKET SIZE, BY CENTRAL NUTRITION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL EMPTY IV BAGS MARKET SIZE, BY CENTRAL NUTRITION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL EMPTY IV BAGS MARKET SIZE, BY CENTRAL NUTRITION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL EMPTY IV BAGS MARKET SIZE, BY CENTRAL NUTRITION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL EMPTY IV BAGS MARKET SIZE, BY CENTRAL NUTRITION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL EMPTY IV BAGS MARKET SIZE, BY CENTRAL NUTRITION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL EMPTY IV BAGS MARKET SIZE, BY PERIPHERAL NUTRITION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL EMPTY IV BAGS MARKET SIZE, BY PERIPHERAL NUTRITION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL EMPTY IV BAGS MARKET SIZE, BY PERIPHERAL NUTRITION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL EMPTY IV BAGS MARKET SIZE, BY PERIPHERAL NUTRITION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL EMPTY IV BAGS MARKET SIZE, BY PERIPHERAL NUTRITION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL EMPTY IV BAGS MARKET SIZE, BY PERIPHERAL NUTRITION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL EMPTY IV BAGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL EMPTY IV BAGS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. AMERICAS EMPTY IV BAGS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 150. AMERICAS EMPTY IV BAGS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 151. AMERICAS EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 152. AMERICAS EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 153. AMERICAS EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2018-2024 (USD MILLION)
  • TABLE 154. AMERICAS EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2025-2032 (USD MILLION)
  • TABLE 155. AMERICAS EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 156. AMERICAS EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 157. AMERICAS EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 158. AMERICAS EMPTY IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 159. AMERICAS EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 161. AMERICAS EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. NORTH AMERICA EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 170. NORTH AMERICA EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2018-2024 (USD MILLION)
  • TABLE 172. NORTH AMERICA EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2025-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 174. NORTH AMERICA EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 176. NORTH AMERICA EMPTY IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 178. NORTH AMERICA EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 180. NORTH AMERICA EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 182. NORTH AMERICA EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. LATIN AMERICA EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. LATIN AMERICA EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2018-2024 (USD MILLION)
  • TABLE 190. LATIN AMERICA EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2025-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 192. LATIN AMERICA EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 194. LATIN AMERICA EMPTY IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 196. LATIN AMERICA EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 198. LATIN AMERICA EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 200. LATIN AMERICA EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 202. LATIN AMERICA EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA EMPTY IV BAGS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA EMPTY IV BAGS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA EMPTY IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE EMPTY IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. MIDDLE EAST EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. MIDDLE EAST EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2018-2024 (USD MILLION)
  • TABLE 244. MIDDLE EAST EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2025-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 246. MIDDLE EAST EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 247. MIDDLE EAST EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 248. MIDDLE EAST EMPTY IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 249. MIDDLE EAST EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 250. MIDDLE EAST EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 252. MIDDLE EAST EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 253. MIDDLE EAST EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 254. MIDDLE EAST EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 255. MIDDLE EAST EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 256. MIDDLE EAST EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 257. AFRICA EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. AFRICA EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. AFRICA EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. AFRICA EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. AFRICA EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2018-2024 (USD MILLION)
  • TABLE 262. AFRICA EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2025-2032 (USD MILLION)
  • TABLE 263. AFRICA EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 264. AFRICA EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 265. AFRICA EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 266. AFRICA EMPTY IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 267. AFRICA EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 268. AFRICA EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 269. AFRICA EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 270. AFRICA EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 271. AFRICA EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 272. AFRICA EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 273. AFRICA EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 274. AFRICA EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 275. ASIA-PACIFIC EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. ASIA-PACIFIC EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. ASIA-PACIFIC EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 278. ASIA-PACIFIC EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 279. ASIA-PACIFIC EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2018-2024 (USD MILLION)
  • TABLE 280. ASIA-PACIFIC EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2025-2032 (USD MILLION)
  • TABLE 281. ASIA-PACIFIC EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 282. ASIA-PACIFIC EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 283. ASIA-PACIFIC EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 284. ASIA-PACIFIC EMPTY IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 285. ASIA-PACIFIC EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 286. ASIA-PACIFIC EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 287. ASIA-PACIFIC EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 288. ASIA-PACIFIC EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 289. ASIA-PACIFIC EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 290. ASIA-PACIFIC EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 291. ASIA-PACIFIC EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 292. ASIA-PACIFIC EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 293. GLOBAL EMPTY IV BAGS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 294. GLOBAL EMPTY IV BAGS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 295. ASEAN EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 296. ASEAN EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 297. ASEAN EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 298. ASEAN EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 299. ASEAN EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2018-2024 (USD MILLION)
  • TABLE 300. ASEAN EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2025-2032 (USD MILLION)
  • TABLE 301. ASEAN EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 302. ASEAN EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 303. ASEAN EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 304. ASEAN EMPTY IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 305. ASEAN EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 306. ASEAN EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 307. ASEAN EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 308. ASEAN EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 309. ASEAN EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 310. ASEAN EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 311. ASEAN EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 312. ASEAN EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 313. GCC EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 314. GCC EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 315. GCC EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 316. GCC EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 317. GCC EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2018-2024 (USD MILLION)
  • TABLE 318. GCC EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2025-2032 (USD MILLION)
  • TABLE 319. GCC EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 320. GCC EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 321. GCC EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 322. GCC EMPTY IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 323. GCC EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 324. GCC EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 325. GCC EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 326. GCC EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 327. GCC EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 328. GCC EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 329. GCC EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 330. GCC EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 331. EUROPEAN UNION EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 332. EUROPEAN UNION EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 333. EUROPEAN UNION EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 334. EUROPEAN UNION EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 335. EUROPEAN UNION EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2018-2024 (USD MILLION)
  • TABLE 336. EUROPEAN UNION EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2025-2032 (USD MILLION)
  • TABLE 337. EUROPEAN UNION EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 338. EUROPEAN UNION EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 339. EUROPEAN UNION EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 340. EUROPEAN UNION EMPTY IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 341. EUROPEAN UNION EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 342. EUROPEAN UNION EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 343. EUROPEAN UNION EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 344. EUROPEAN UNION EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 345. EUROPEAN UNION EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 346. EUROPEAN UNION EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 347. EUROPEAN UNION EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 348. EUROPEAN UNION EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 349. BRICS EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 350. BRICS EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 351. BRICS EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 352. BRICS EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 353. BRICS EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2018-2024 (USD MILLION)
  • TABLE 354. BRICS EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2025-2032 (USD MILLION)
  • TABLE 355. BRICS EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 356. BRICS EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 357. BRICS EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 358. BRICS EMPTY IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 359. BRICS EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 360. BRICS